Welcome to this edition of The BlindSpot, a production by The Middle East Policy Council and co-hosted by Shannon Beacom and Medlir Mema. The aim of The BlindSpot is to provide fresh perspectives on important issues and developments in the Middle East.
The new US administration announced earlier this month that it would revoke the “terrorist group” designation of Iranian-backed Houthi rebels in Yemen in an effort to move forward the peace process in the country.
It was understood from the beginning that one of US President Joe Biden’s greatest foreign-policy challenges would be a return to the negotiation table with Iran. Mr.
Two weeks since one of the deadliest terrorist attacks in Baghdad in recent years, regional observers continue to ask important questions about Iraq’s stability.
The US Department of State issued a statement in the waning days of the Trump administration designating the Yemeni military rebel forces Ansar Allah, currently occupying the capital and large swaths of the country, as a terrorist group.
As rumors mount regarding Iranian Supreme Leader Ali Khamenei’s health, the Trump administration continues to pursue actions that are likely to leave behind a complicated reality for the incoming administration.
News of the approval for the mass production of several Covid-19 vaccines has buoyed up governments and people across the world.
The brazen assassination of Iranian scientist Mohsen Fakhrizadeh threatens to destabilize the region anew.
The incoming Biden administration has made it clear that it intends to reengage with Iran. Just this week US President-elect Joe Biden said his administration would seek to rejoin the nuclear deal if Iran meets certain conditions.